Predictive Modeling And Risk Stratification Of A Medication Therapy Regimen

• US 20080126131A1
• Filed: 07/17/2006
• Published: 05/29/2008
• Est. Priority Date: 07/17/2006
• Status: Abandoned Application

• Current Assignee: Walgreen Co. (Walgreens Boots Alliance Incorporated)
• Original Assignee: Walgreen Co. (Walgreens Boots Alliance Incorporated)
• Inventors: Lou, Youbei
• Application Number:
  US11/458,080
• Publication Number:
  US 20080126131A1
• Time in Patent Office: Days
• US Class Current: 705/3
• CPC Class Codes: G06Q 10/10 Office automation; Time management
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/30 for calculating health indices; for individual health risk assessment
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders

Abstract

A method of predictive modeling and risk stratification of a medication therapy regimen identifies potentially adverse health outcomes resulting from the medication therapy regimen. Methods of predictive modeling and risk stratification of a medication therapy regimen and intervention thereof are provided herein. The methods of predictive modeling and risk stratification include receiving medical condition and medication information, evaluating the medical condition and medication information to identify an adverse health outcome and evaluating the likelihood of the identified adverse health outcome based on the medical condition and medication information. Persons may be identified from among a plurality of persons for medication therapy regimen intervention based on the likelihood of the adverse health outcome. The methods may also include receiving medical insurance information and creating an intervention severity index based on the medication and medical insurance information, which relates to a degree of urgency in intervening in a medial treatment of a person.

Claims

1. A method of modeling and stratifying intervention groups comprising:

receiving medical condition data relating to a medical condition associated with each of a plurality of persons;

receiving medication data relating to a medication being used by each of the plurality of persons;

evaluating the medical condition data and the medication data to identify an adverse health outcome for each of the plurality of persons;

evaluating the likelihood of the identified adverse health outcome for each of the plurality of persons based on the medical condition data and the medication data; and

identifying one or more persons from the plurality of persons for medication therapy regimen intervention based on the likelihood of the identified adverse health outcome.

2. The method of claim 1, wherein the medication therapy regimen intervention comprises contacting one or more of the group consisting of:

the person and a medical provider for the person.

3. The method of claim 1, further comprising receiving insurance data for each of the plurality of persons.

4. The method of claim 3, wherein the insurance data comprises at least one of the group consisting of:

medical insurance claims data and prescription insurance claims data.

5. The method of claim 1, wherein receiving medical condition data comprises receiving medical insurance data from a medical insurer, the medical insurance data relating to one or more medical insurance claims by each of the plurality of persons.

6. The method of claim 1, wherein receiving medication data comprises receiving medication data from a pharmacy, the medication data relating to a medication prescription for each of the plurality of persons.

7. The method of claim 1, further comprising:

creating a first group of persons from the plurality of persons based on the likelihood of the identified adverse health outcome for each of the plurality of persons; and

creating a second group of persons from the plurality of persons based on the likelihood of the identified adverse health outcome for each of the plurality of persons.

8. The method of claim 7, wherein the first group comprises a higher likelihood of an identified adverse health outcome than the second group, the method further comprising assigning a first medication therapy regimen intervention urgency level to the first group and assigning a second intervention urgency level to the second group.

9. The method of claim 8, further comprising intervening in a medical treatment of a person based on the first or second intervention urgency level.

10. A method of intervening in a medical treatment of a person comprising:

receiving medication data relating to one or more prescriptions for a person;

receiving medical insurance data relating to one or more medical insurance claims for the person;

evaluating the medication data and the medical insurance data to identify an adverse health outcome;

creating an intervention severity index based on the medication data and the medical insurance data, wherein the intervention severity index relates to a degree of urgency in intervening in a medial treatment of the person; and

determining a method of communication to carry out a medical intervention based on the intervention severity index.

11. The method of claim 10, wherein creating an intervention severity index comprises evaluating the likelihood of the identified adverse health outcome for the person based on the medical insurance data and the medication data.

12. The method of claim 10, wherein the medication data relates to a plurality of medications being used by the person and wherein evaluating the medical insurance data and the medication data comprises evaluating an interaction between the plurality of medications being used by the person.

13. The method of claim 10, wherein evaluating the medical insurance data and the medication data comprises evaluating an interaction between the medication and the medical condition.

14. The method of claim 10, wherein the medication data comprises data relating to utilization of the medication.

15. The method of claim 10, wherein the medication data comprises data relating to the duration the medication has been used by the person.

16. The method of claim 10, wherein evaluating the medical insurance data and the medication data comprises evaluating the utilization of the medication for overutilzation of the medication.

17. The method of claim 10, wherein evaluating the medical insurance data and the medication data comprises evaluating compliance with a medication therapy regimen.

18. The method of claim 10, wherein evaluating the medical insurance data and the medication data comprises evaluating the medication data for a duplication of the medication.

19. The method of claim 10, wherein determining a method of communication to carry out a medical intervention comprises determining whether to contact at least one of the group consisting of:

the person and a medical provider of the person.

20. The method of claim 10, further comprising intervening in a medical treatment of the person in response to an identified adverse health outcome based on the age data, the medical condition data and the medication data.

21. A method of conducting a business relating to predictive modeling and risk stratification of a medication therapy regimen, the method comprising:

receiving a request to subscribe to a medication therapy management service;

providing a medication therapy management service relating to predictive modeling and risk stratification of a medication therapy regimen, wherein the medication therapy management service includes intervening in the medication therapy regimen if the medication therapy management service predicts an identified adverse health outcome associated with the medication therapy regimen;

submitting a reimbursement code in response to the intervention; and

receiving reimbursement for the service in response to the reimbursement code.

22. The method of claim 21, wherein the intervention in the medication therapy regimen comprises creating a new medication therapy regimen for a person and providing the person with the new medication therapy regimen.

23. The method of claim 22, wherein creating a new medication therapy regimen for the person comprises consulting with a medical provider associated with the person to determine the new medication therapy regimen.

24. The method of claim 21, wherein providing a medication therapy management service relating to predictive modeling and risk stratification of a medication therapy regimen comprises:

receiving medical condition data relating to a medical condition associated with each of a plurality of persons;

receiving medication data relating to a medication being used by each of the plurality of persons;

evaluating the medical condition data and the medication data to identify an adverse health outcome for each of the plurality of persons; and

evaluating the likelihood of the identified adverse health outcome for each of the plurality of persons based on the medical condition data and the medication data.

25. The method of claim 21, wherein providing a medication therapy management service relating to predictive modeling and risk stratification of a medication therapy regimen comprises:

receiving medication data relating to one or more prescriptions for a person;

receiving medical insurance data relating to one or more medical insurance claims for the person;

evaluating the medication data and the medical insurance data to identify an adverse health outcome; and

creating an intervention severity index based on the medication data and the medical insurance data, wherein the intervention severity index relates to a degree of urgency in intervening in a medial treatment of the person.

26. The method of claim 21, wherein the reimbursement code comprises a National Council for Prescription Drug Programs Professional Pharmacy Services code.